VIVO - Meridian Bioscience Non-GAAP EPS of $0.35 revenue of $88.3M February, 04 2022 08:06 AM Meridian Bioscience Inc. Meridian Bioscience press release (NASDAQ:VIVO): Q1 Non-GAAP EPS of $0.35. Revenue of $88.3M (-5.0% Y/Y). For further details see: Meridian Bioscience Non-GAAP EPS of $0.35, revenue of $88.3M